Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06500780 · ClinicalTrials.gov registry record · NA

Equipping Patients Using Interventions for Pain and Depression

A NA study of Depression and Chronic Pain, sponsored by Indiana University.

Recruiting
Registry status
NA
Development phase
304
Enrollment target
1
Study location

NCT06500780: Recruiting NA study of Depression and Chronic Pain, sponsored by Indiana University.

NCT06500780 is a NA study of Depression and Chronic Pain that is actively recruiting participants, run by Indiana University. The registered enrollment target is 304 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06500780, a NA study of Depression and Chronic Pain, is actively recruiting participants, sponsored by Indiana University.

RECRUITING
Registry status
NA
Development phase
304 participants
Enrollment target
1
Study location

Study Summary

This project is part of the NIH Helping to End Addiction Long-term (HEAL) initiative (https://heal.nih.gov/). This randomized controlled trial (RCT) is phase 2 of a two-phase, 5-year project with the overarching goal of testing a decision aid (DA)/coaching intervention, tailored to Black patients with comorbid chronic pain and depression, to encourage use of and adherence to nonpharmacological pain treatments (NPTs). This 2-arm trial will randomize 304 patients with comorbid chronic musculoskeletal pain and depression in primary care from an urban safety-net health system (Eskenazi). After the baseline assessment, patients randomized to the intervention will be asked to participate in 4 coaching sessions over approximately 12 weeks. Sessions will use Motivational Interviewing principles to foster openness to NPTs and self-efficacy by helping patients identify their goals and priorities, understand their NPT options, prepare them to discuss and choose options with their primary care providers (PCPs), and reinforce these choices to foster maintenance of these changes. DA contents will be integrated into these sessions, which will facilitate discussion of these options with their PCP. The first 3 sessions take place prior to the patient's next scheduled PCP visit; the final session occurs after this visit. Assessments will be conducted at baseline, 3 months (i.e., after completing the final coaching session), and 6 months. Patients randomized to the wait-list control group will receive usual care (in addition to study assessments at baseline, 3 months, and 6 months). After completing the final assessment, they will then be given the DA and offered a 20-minute coaching session to walk them through it.

Primary Outcome

The pain interference score averages seven ratings, 0 (does not interfere) to 10 (completely interferes).

Interventions

  • BEHAVIORAL Coaching and Decision Aid

Study Locations (1)

Indiana

  • Eskenazi Health Primary Care - Indianapolis

Trial Details

FieldValue
Enrollment Target 304 participants
Start Date 2024-08-13
Est. Completion 2027-05-31
Phase NA
Indiana University

890 total trials

What NCT06500780 shows while recruiting

NCT06500780 is an interventional study that assigns participants to a tested intervention. The registered 304 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (61% lower).

The record links to 4 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Coaching and Decision Aid is the first listed.

NCT06500780 reports a single indexed study location in Indiana.

Frequently Asked Questions

What is clinical trial NCT06500780 about?

NCT06500780 is a clinical study titled "Equipping Patients Using Interventions for Pain and Depression". This project is part of the NIH Helping to End Addiction Long-term (HEAL) initiative (https://heal.nih.gov/). This randomized controlled trial (RCT) is phase 2 of a two-phase, 5-year project with the overarching goal of testing a decision aid (DA)/coaching intervention, tailored to Black patients wi...

What is the current status of trial NCT06500780?

This trial is currently recruiting. It is a NA study. The enrollment target is 304 participants. The study started on 2024-08-13. Estimated completion is 2027-05-31.

What conditions does trial NCT06500780 study?

This clinical trial studies the following conditions: Depression, Chronic Pain, Musculoskeletal Pain, Health Equity.

What interventions are being tested in trial NCT06500780?

The interventions under investigation include: Coaching and Decision Aid (BEHAVIORAL).

Who is sponsoring clinical trial NCT06500780?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06500780 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06500780's enrollment target sits among peer trials

304 139th of 679 higher than 541 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04750616 · 304 participants · Phase 2

    NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial

  • NCT04994717 · 304 participants · Phase 3

    Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia

  • NCT06036147 · 304 participants · NA

    Concussion Health Improvement Program

  • NCT06096844 · 304 participants · Phase 3

    Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT06500780, the US trial registry maintained by the National Library of Medicine. NCT06500780 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.